Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
about
Quantitative contrast-enhanced ultrasound imaging: a review of sources of variabilityImaging of liver cancer.Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery.Clinical utility of imaging for evaluation of hepatocellular carcinomaUltrasound contrast materials in cardiovascular medicine: from perfusion assessment to molecular imagingUltrasound contrast agents.A review of low-intensity ultrasound for cancer therapy.High-intensity focused ultrasound ablation enhancement in vivo via phase-shift nanodroplets compared to microbubbles.Washout Ratio in the Hepatic Vein Measured by Contrast-Enhanced Ultrasonography to Distinguish Between Inflammatory and Noninflammatory Hepatic Disorders in Dogs.Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver DiseaseSafety assessment in rats and dogs of Acoustic Cluster Therapy, a novel concept for ultrasound mediated, targeted drug delivery.Phase-change contrast agents for imaging and therapy.Recent advances in the imaging of hepatocellular carcinomaA case of sclerosing angiomatoid nodular transformation of the spleen: correlations between contrast-enhanced ultrasonography and histopathologic findings.Contrast-enhanced ultrasonography: advance and current status in abdominal imaging.Theranostic mRNA-loaded microbubbles in the lymphatics of dogs: implications for drug delivery.Renal retention of lipid microbubbles: a potential mechanism for flank discomfort during ultrasound contrast administration.Tumor functional and molecular imaging utilizing ultrasound and ultrasound-mediated optical techniques.Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.The role of poly(ethylene glycol) brush architecture in complement activation on targeted microbubble surfacesImage of tumor metastasis and inflammatory lymph node enlargement by contrast-enhanced ultrasonographyTargeted renal therapies through microbubbles and ultrasound.Decreased accumulation of ultrasound contrast in the liver of nonalcoholic steatohepatitis rat model.Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosisContrast enhanced ultrasound of hepatocellular carcinoma.Diagnosis of liver cirrhosis with contrast-enhanced ultrasoundDetection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis modelAssessment of hepatic VX(2) tumors with combined percutaneous transhepatic lymphosonography and contrast-enhanced ultrasonographic imagingContrast enhanced ultrasound: Roles in immediate post-procedural and 24-h evaluation of the effectiveness of thermal ablation of liver tumorsContrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studiesUltrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancerThe application of microbubbles for targeted drug delivery.Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocePotential value of sonazoid-enhanced intraoperative laparoscopic ultrasonography for liver assessment during laparoscopy-assisted colectomy.Investigative safety science as a competitive advantage for Pharma.
P2860
Q24605553-5D4B3392-D308-4892-88E4-6B0D799AAEEBQ24654739-50104308-A2D7-40EA-8047-263D81C86E6AQ26781564-4FED249E-965B-4B42-BB6A-27F779C44AAEQ26823224-0ECFEA32-6BBE-4EC4-93F1-B2D20DDC7F74Q26853667-D01AD9EC-63A2-4D7C-88CF-E526DD9D88FFQ28077669-66E78A6F-C9E8-4BDD-BF12-7825D134898FQ28082093-086D3703-8E1B-40D0-878F-D20CCBCE0BE1Q30279234-10D3AC54-AA91-4989-A6CD-CBD1CAC5B8F8Q30356064-AEB90246-E372-4355-A5AD-242B04DCD2FDQ30359316-C18A343B-A71F-49CC-A801-8153A9884751Q30362727-5980651A-1540-4A22-AE8E-DDDC1D3619F3Q30365651-18CA99CF-5D71-4DE9-AA83-F36CF74D853AQ30373053-49F61A51-6B42-47BB-8633-BD4D8305C769Q30415186-ADF713D2-4519-4FF4-A215-07E3BC0C66DEQ30418860-928C0A30-83B9-48BB-BC9A-5EF8E8F04835Q30421027-5BCF817E-D872-4387-BDF5-FD0739C84143Q30422136-400E98B2-C555-4725-AA3C-A957C169A6B1Q30424128-2637D68B-BE65-448D-AF70-D671245AD2F5Q30441019-22304BDE-3E12-4835-AE4A-E3A8BE9E781DQ30462259-9C024088-0CD5-4252-A6FB-297DD4CDD041Q30464013-E435F5F6-343B-406A-8E24-E95996AA99EDQ30471610-766DCE31-D8FE-4656-8902-F06FF63DBFE5Q30472688-6E21026A-E729-4284-96A2-74DDE12B68E1Q30473123-04D0C1E5-332C-4D4C-81A4-8049BB788132Q30478078-02A8156D-5B6A-469E-A8DB-87F9B6FC03A8Q30478156-62091A66-2B7F-4D4F-AC54-7C594D220001Q30478158-3110AC5B-B60B-458A-8DAC-020AE0BDC841Q30478166-0068F6EC-6315-4368-9F6D-73FC5C241EEBQ30479629-97667333-FFA3-4463-9AE6-14242DD1A0C1Q30486045-0C01DCD4-42B7-46C6-A47B-B9EF64C4F7D0Q30487612-FA33EDB8-99B5-4401-86A5-EDC5371D5A93Q30533586-68BF31F9-F302-4B98-BE91-ECDADA0247A0Q33576986-8DF15FE9-A1DA-4D31-805B-6CD96599BF7AQ33830708-F2440445-F20F-4EF5-B11B-AE25F9DB09D1Q34115828-AE3451B6-E967-4E43-85D4-E9F5914B8C87Q36637298-A70CF4F0-14A8-4681-A926-96DE158C1D94Q36945842-D468EEF4-91CB-4900-B9A3-FE468451A1D2Q37429938-EF3167EA-6AA7-41DF-8C6E-E65620990826Q37631606-91C243BC-0CA6-4392-9C88-106CED8A2D63Q38024403-270D0ADA-85BB-47DB-84B2-44107BB506AF
P2860
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
@ast
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
@en
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
@nl
type
label
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
@ast
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
@en
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
@nl
prefLabel
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
@ast
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
@en
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
@nl
P2093
P1476
Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells.
@en
P2093
Fuminori Moriyasu
Hiroko Iijima
Kyosuke Yanagisawa
Miyata Yuki
Takeo Miyahara
P304
P356
10.1016/J.ULTRASMEDBIO.2006.08.008
P577
2007-02-01T00:00:00Z